二酶8 (PDE8):分布和细胞表达以及与阿尔茨海默氏症疾病的关联
Nian-Zhuang Qiu1, Hui-Mei Hou2, Tian-Yang Guo1
1Institute of Pharmacology, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, 271016, Shandong, China.
Neurochemical research
|May 23, 2024
概括
二酶8 (PDE8) 在大脑中分布广泛,其表达随着年龄的变化而改变阿尔茨海默氏症.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 固酶8 (PDE8) 调节细胞内循环腺单酸盐 (cAMP) 的水平.
- PDE8在中枢神经系统 (CNS) 中的作用及其与阿尔茨海默氏症 (AD) 病原发生的潜在联系在很大程度上是未知的.
研究的目的:
- 研究小鼠大脑中PDE8亚型 (PDE8A和PDE8B) 的分布和表达模式.
- 在三重转基因小鼠模型中检查阿尔茨海默病进展期间PDE8表达的变化.
主要方法:
- 西部斑点 (WB) 分析以确定PDE8A和PDE8B在各种组织和大脑区域的表达.
- 多重免疫光染色以定位特定神经细胞类型内的PDE8表达.
- 对海马体和大脑皮层中PDE8表达的比较分析,老年三重转基因AD小鼠和野生类型对照.
主要成果:
- PDE8在多个器官中得到广泛表达,包括与认知功能相关的关键大脑区域的显著分布.
- 在神经元,微质细胞和星球细胞中检测到PDE8A,而在神经元和微质细胞中检测到PDE8B.
- 在AD模型小鼠中,PDE8表达,特别是海马中的PDE8A和大脑皮层中的PDE8B,显示了年龄相关的变化,与野生类型相比,两性总体上调.
结论:
- PDE8在大脑中广泛分布,并且存在于各种神经细胞类型中.
- 改变PDE8表达与老鼠模型中阿尔茨海默病的进展相关.
- PDE8代表了阿尔茨海默病预防和治疗的潜在治疗标.
相关概念视频
Alzheimer's Disease: Overview
465
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
465
Alzheimer's Disease: Treatment
180
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
180
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
IP3/DAG Signaling Pathway
12.0K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.0K
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K


